FDA asks drugmakers to remove suicide warnings from weight-loss drugs

Posted on January 13, 2026

The U.S. health regulator asked drugmakers today to remove warnings about a potential risk of suicidal thoughts from widely used GLP-1 weight-loss drugs, including Novo ‍Nordisk’s Wegovy and Eli Lilly’s Zepbound.

See the original article at: Honolulu Star-Advertiser

<--- Like this post? You know what to do.

Comments are closed.